Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Medical Hypotheses|December 1, 2020
Diminishing reactive adipogenesis leads to disease progression of oral submucous fibrosisJagadish Hosmani, Shankargouda Patil, Hussain Mohammed Almubarak, et al.
Medicina (Kaunas, Lithuania)|June 2, 2021
Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic ReviewJagadish Hosmani, Shazia Mushtaq, Shahabe Saquib Abullais, et al.
Clinical Lung Cancer|February 20, 2021
A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung CancerMalcolm D Mattes, Timothy D Eubank, Mohammed Almubarak, et al.
Practical Radiation Oncology|November 5, 2025
A Case for Caution in a New Era of Managing Patients with Locally Advanced Non-Small Cell Lung Cancer: Fatal Bronchial-Esophageal Fistula After Neoadjuvant Chemo-Immunotherapy Followed by Definitive Chemoradiation TherapyKaitlyn Heintzelman, John C Knoth, Casey Mozingo, et al.
Frontiers in Oncology|July 8, 2014
Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyondAlexander Chi, Nam Phong Nguyen, James S Welsh, et al.
World Journal of Stem Cells|November 12, 2020
Proteomic profiling of various human dental stem cells - a systematic reviewJagadish Hosmani, Khalil Assiri, Hussain Mohammed Almubarak, et al.
BMC Oral Health|January 11, 2019
Oral hygiene practice and periodontal status among two tribal population of Telangana state, India- an epidemiological studyShaik Mohammed Asif, Shaik Naheeda, Khalil Ibrahim Assiri, et al.
Translational Lung Cancer Research|January 20, 2025
Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomesZuan-Fu Lim, Xiaoliang Wu, Lin Zhu, et al.
European Journal of Endocrinology|March 25, 2022
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinomaSteven G Waguespack, Alexander Drilon, Jessica J Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II TrialEzra E W Cohen, Lisle Nabell, Deborah J Wong, et al.
Pageof 3